Free shipping on all orders over $ 500

AP1903 (Rimiducid)

Cat. No. M10066
AP1903 (Rimiducid) Structure
Synonym:

Rimiducid

Size Price Availability Quantity
1mg USD 135  USD135 In stock
2mg USD 195  USD195 In stock
5mg USD 350  USD350 In stock
10mg USD 510  USD510 In stock
25mg USD 850  USD850 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rimiducid (AP1903) is a lipid-permeable tacrolimus analogue acts by cross-linking the FKBP domains. Rimiducid (AP1903) dimerizes the Caspase 9 suicide switch and rapidly induces apoptosis. In vivo, Rimiducid (0.01, 0.1, 1, 10, and 100 mg/kg; i.v.) elicits a dose-dependent decrease in serum human GH levels, with a half-maximal effective dose of 0.4±0.1 mg/kg.

*The compound is unstable in solutions, freshly prepared is recommended

Chemical Information
Molecular Weight 1411.63
Formula C78H98N4O20
CAS Number 195514-63-7
Solubility (25°C) DMSO 48 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] D C Thomis, et al. Blood. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

[2] T Clackson, et al. Proc Natl Acad Sci U S A. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity

Related FAS Products
GSK837149A 

GSK837149A is a selective inhibitor of human Fatty Acid Synthase (FASN) targeting the KR domain. GSK837149A has reversible inhibition effect on FASN and selectivity for type I FASN (Ki=30 nM). GSK837149A is also a competitive inhibitor of NADPH and a non-competitive inhibitor of acetoacetyl-CoA. GSK837149A can be used for the research of obesity and breast cancer.

IPI-9119

IPI-9119 is an orally active, selective and irreversible Fatty Acid Synthase (FASN) inhibitor, with an IC50 of 0.3 nM.

Eicosapentaenoic acid ethyl ester

Eicosapentaenoic acid ethyl ester (AMR101, EPA ethyl ester, Ethyl eicosapentaenoate) is an omega-3 fatty acid agent that significantly reduces the triglyceride (TG) levels and improves other lipid parameters without significantly increasing the low-density lipoprotein (LDL) cholesterol levels.

FT113

FT113 is a potent inhibitor of fatty acid synthase(FASN) with ic50 of 213 nM.

PF429242 dihydrochloride

PF429242 dihydrochloride is a reversible and competitive SREBP site 1 protease (S1P) inhibitor with an IC50 of 175 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: AP1903 (Rimiducid), Rimiducid supplier, FAS, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.